posted
The bulk of them were not true buys. Look at the transaction codes and on the big ones and you'll see a "j" which means "other type of transaction". Those were multi million issuance of shares in lieu of pay and to satisfy debt. In other words, dilution. This stock was diluted by 50% between March and May. As I said in an earlier post, you might get a pop on this one as it's at a level where it has done so in the past but there IS dilution happening here and it IS going to continue. Read their last 10Q in its entirety, you'll see why I say that. Those are the reasons I chose to pass on it, I don't see it going anywhere but down. If you buy it or own it, I hope I'm wrong.
IP: Logged |
posted
generally this stock which i have watched for the better half of a year has always rebounded to four cents from two....this play is dictated by past performance which continues to repeat in a cycle
-------------------- pink floyds "money" is the way to live.......
IP: Logged |
posted
insiders were given stock as options but have yet to exercise selling which i bet that they wont....stock is very attractive at .021 and a nice rebound play
-------------------- pink floyds "money" is the way to live.......
IP: Logged |
posted
i'm not saying that this stock is going to shoot to the moon but out of the many pinks that have a trend....this is one of them the charts do not lie about upticking to 0.04 which at the current price of .021 would give you a very nice gain if held for a month or so.....
-------------------- pink floyds "money" is the way to live.......
IP: Logged |
CARLSBAD, Calif., June 24, 2005 /PRNewswire-FirstCall via COMTEX/ -- BIOPRO Technology, a division of FemOne, Inc. a publicly held Nevada corporation (FEMO, Trade) announced the launch of its new whole food nutrition product, BIOPRODUCE(TM).
BIOPRODUCE is a highly concentrated whole food supplement to be taken daily in two formulations, Fruits and Berries, and Vegetables. The formulas are power packed with natural food additives and BIOPRODUCE's unique formulation works synergistically with the body's cells to provide essential nutrients for total well being.
BIOPRODUCE compliments the BIOPRO Technology divisions product line designed to enhance overall health and wellness, and to combat the effects of external stress including the harmful effects of electromagnetic radiation.
Commenting on the new products, FemOne's CEO, Ray W. Grimm, Jr. stated: "We are excited to introduce the BIOPRODUCE products to our customers. They are another outstanding example of BIOPRO's mission of providing a new generation of wellness solutions in a number of different product categories to people around the globe. Not only do our Fruits and Berries and Vegetable capsules include whole-food nutrition formulas that combine over 20 fruits, berries and vegetables, designed to compliment your diet so that your body can get its daily nutrients, they are also exposed to BIOPRO's unique Energy Elevation Process (EEP), designed to maximize product absorption and utilization. BIOPRODUCE is another essential element in BIOPRO helping people to effectively deal with environmental toxins and enhance their overall well being. We have launched this product in the United States initially, and the product will be available in Australia and New Zealand through our subsidiary BIOPRO Australasia in the next three months," Grimm added.
The information contained in this press release should be read in connection with the Company's Annual Report on Form 10-KSB for the year ended December 31, 2004 and our subsequent filings. Included in our Annual Report for the year ended December 31, 2004, is the Report from the Company's Independent Registered Public Accounting Firm and information necessary for an understanding of the Company.
About FemOne, Inc.
FemOne, Inc. (FEMO, Trade), based in Carlsbad, California is sales and marketing company with distribution in the United States, Canada, Australia and New Zealand. More information about FemOne and its products can be found on the company's web sites at www.femone.com or www.bioprotechnology.com, by e-mail at FEMOIR@femone.com or by calling FemOne Inc. at (760) 448-2498.
Any statements made in this press release which are not historical facts contain certain forward-looking statements, as such term is defined in the Private Litigation Reform Act of 1995, concerning potential developments affecting the business, prospects, financial condition and other aspects of the company to which this release pertains. The actual results of the specific items described in this release, and the company's operations generally, may differ materially from what is projected in such forward-looking statements. Although such statements are based upon the best judgments of management of the company as of the date of this release, significant deviations in magnitude, timing and other factors may result from business risks and uncertainties including, without limitation, the company's dependence on third parties, general market and economic conditions, technical factors, the availability of outside capital, receipt of revenues and other factors, many of which are beyond the control of the company. The company disclaims any obligation to update information contained in any forward-looking statement.
-------------------- pink floyds "money" is the way to live.......
IP: Logged |